Last Posted: Feb 28, 2020
- Issues and Questions Surrounding Screening for Cognitive Impairment in Older Patients.
Petersen Ronald C et al. JAMA 2020 Feb (8) 722-724 - [Direct-to-consumer genetic tests in the consulting room].
Gerrits Elianne M et al. Nederlands tijdschrift voor geneeskunde 2019 Nov 163 - Assessment of Demographic, Genetic, and Imaging Variables Associated With Brain Resilience and Cognitive Resilience to Pathological Tau in Patients With Alzheimer Disease.
Ossenkoppele Rik et al. JAMA neurology 2020 Feb - Predicting sporadic Alzheimer's disease progression via inherited Alzheimer's disease-informed machine-learning.
Franzmeier Nicolai et al. Alzheimer's & dementia : the journal of the Alzheimer's Association 2020 Feb - Alzheimer's disease susceptibility gene apolipoprotein e (APOE) and blood biomarkers in UK Biobank (N=395,769).
A Ferguson et al, MedRXIV, Februray 13, 2020 - Alzheimer disease risk genes: 29 and counting.
Bertram Lars et al. Nature reviews. Neurology 2019 15(4) 191-192 - Machine Learning Predictive Models Can Improve Efficacy of Clinical Trials for Alzheimer's Disease1,2.
Ezzati Ali et al. Journal of Alzheimer's disease : JAD 2020 Jan - Convolution neural network-based Alzheimer's disease classification using hybrid enhanced independent component analysis based segmented gray matter of T2 weighted magnetic resonance imaging with clinical valuation.
Basheera Shaik et al. Alzheimer's & dementia (New York, N. Y.) 2019 5974-986 - Temporal association of neuropsychological test performance using unsupervised learning reveals a distinct signature of Alzheimer's disease status.
Joshi Prajakta S et al. Alzheimer's & dementia (New York, N. Y.) 2019 5964-973 - Predicting Amyloid-β Levels in Amnestic Mild Cognitive Impairment Using Machine Learning Techniques.
Ezzati Ali et al. Journal of Alzheimer's disease : JAD 2019 Dec
.png)
No hay comentarios:
Publicar un comentario